Skip to main content
. 2018 Jan 12;103(4):1402–1407. doi: 10.1210/jc.2017-01838

Figure 1.

Figure 1.

Plasma glucose concentrations during the three hyperglycemic clamp studies performed at baseline and on days 2 and 14 after the start of empagliflozin therapy. Conc., concentration.